Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter McCluskey

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|August 7, 2010
Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionAnne J Lee, Peter McCluskey
Lancet (London, England)|December 14, 2004
The eye in systemic inflammatory diseasesPeter McCluskey, Richard J Powell
Clinical & Experimental Ophthalmology|July 23, 2017
Largest reported orbital solitary fibrous tumourLinda Zheng, Peter McCluskey, Raf Ghabrial
Frontiers in Immunology|January 20, 2021
Recent Developments in HLA B27 Anterior UveitisDenis Wakefield, Daniel Clarke, Peter McCluskey
Ocular Immunology and Inflammation|January 20, 2022
Is There a Safe Systemic Corticosteroid Dose?Denis Wakefield, William Yates, Peter McCluskey
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 7, 2007
Ocular comfort of combination glaucoma therapies: brimonidine 0.2%/timolol 0.5% compared with dorzolamide 2%/timolol 0.5%Kenny Chan, Madalena Testa, Peter McCluskey
Ocular Immunology and Inflammation|December 21, 2012
Acute anterior uveitis in SydneyTanya Karaconji, Zoe Maconochie, Peter McCluskey
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|February 6, 2017
Enhancing Medical Student Education by Implementing a Competency-Based Ophthalmology CurriculumTony Succar, Peter McCluskey, John Grigg
Clinical & Experimental Ophthalmology|August 15, 2019
Intravitreal dexamethasone implants for non-infectious uveitisMatthew McCartney, Peter McCluskey, Sophia Zagora
The Medical Journal of Australia|October 8, 2008
Topical ophthalmic medications: what potential for systemic side effects and interactions with other medications?Ivan Goldberg, Gregory Moloney, Peter McCluskey
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Clinical Ophthalmology (Auckland, N.Z.)|August 7, 2010
Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionAnne J Lee, Peter McCluskey
Lancet (London, England)|December 14, 2004
The eye in systemic inflammatory diseasesPeter McCluskey, Richard J Powell
Clinical & Experimental Ophthalmology|July 23, 2017
Largest reported orbital solitary fibrous tumourLinda Zheng, Peter McCluskey, Raf Ghabrial
Frontiers in Immunology|January 20, 2021
Recent Developments in HLA B27 Anterior UveitisDenis Wakefield, Daniel Clarke, Peter McCluskey
Ocular Immunology and Inflammation|January 20, 2022
Is There a Safe Systemic Corticosteroid Dose?Denis Wakefield, William Yates, Peter McCluskey
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 7, 2007
Ocular comfort of combination glaucoma therapies: brimonidine 0.2%/timolol 0.5% compared with dorzolamide 2%/timolol 0.5%Kenny Chan, Madalena Testa, Peter McCluskey
Ocular Immunology and Inflammation|December 21, 2012
Acute anterior uveitis in SydneyTanya Karaconji, Zoe Maconochie, Peter McCluskey
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|February 6, 2017
Enhancing Medical Student Education by Implementing a Competency-Based Ophthalmology CurriculumTony Succar, Peter McCluskey, John Grigg
Clinical & Experimental Ophthalmology|August 15, 2019
Intravitreal dexamethasone implants for non-infectious uveitisMatthew McCartney, Peter McCluskey, Sophia Zagora
The Medical Journal of Australia|October 8, 2008
Topical ophthalmic medications: what potential for systemic side effects and interactions with other medications?Ivan Goldberg, Gregory Moloney, Peter McCluskey
Pageof 18